These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8614712)

  • 1. [High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience].
    Gava A; Fontan L; Bolner A; Botturi M; Cafaro I; Di Marco A; Marazzato G; Muto P; Orecchia R; Orsatti M; Parisi SS; Rigon A
    Radiol Med; 1996; 91(1-2):118-21. PubMed ID: 8614712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
    Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
    Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
    Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose-rate brachytherapy. The indications, technic and preliminary results].
    Orecchia R; Ragona R; Anglesio S; Tessa M; Del Mastro E; Sannazzari GL
    Minerva Med; 1996; 87(1-2):1-7. PubMed ID: 8610019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraluminal high dose rate brachytherapy combined with external radiotherapy in the treatment of oesophageal cancer.
    Barone D; Coccia G; Marziano C; Tricerri R; Bonelli L; Tomassini E; Bistolfi F
    Panminerva Med; 1993 Jun; 35(2):86-92. PubMed ID: 8414629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer].
    Patonay P; Naszály A; Mayer A
    Strahlenther Onkol; 2007 Feb; 183(2):94-8. PubMed ID: 17294114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [External irradiation combined with intracavitary brachytherapy for esophageal cancer].
    Zhou G; Chen G; Cui S; Sun J; Yang D
    Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):925-7. PubMed ID: 16201172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer.
    Skowronek J; Piotrowski T; Zwierzchowski G
    Brachytherapy; 2004; 3(2):87-94. PubMed ID: 15374540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
    Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
    Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
    Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD
    Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracavitary brachytherapy in esophageal neoplasms. Experience at the Radiology Institute of Brescia].
    La Face B; Micheletti E; Baroncelli G; Catalano G; Huscher A; Cestari R; Ravelli P; Verzelletti L; Galelli M
    Radiol Med; 1997 May; 93(5):607-12. PubMed ID: 9280947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
    Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
    Greene FL; Boulware RJ; Bianco J
    Surg Laparosc Endosc; 1995 Dec; 5(6):425-30. PubMed ID: 8611986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer.
    Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD;
    Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.